通过受体介导的L-阿斯巴拉金酶进入瘤细胞的内化被多氨酸抑制
Igor D Zlotnikov1, Alexander A Ezhov2, Elena V Kudryashova1
1Faculty of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1/3, 119991 Moscow, Russia.
International journal of molecular sciences
|July 29, 2025
概括
将L-阿斯巴拉金酶 (L-ASNase) 与聚氨酸结合,通过向聚氨酸运输系统 (PTS) 来增强其对白血病细胞的吸收和有效性. PTS受体的抑制剂可以阻止这种增强的吸收,揭示了对L-ASNase治疗至关重要的复杂相互作用.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 通过耗尽阿斯巴拉金,L-asparaginase (L-ASNase) 对急性淋巴细胞白血病 (ALL) 的治疗至关重要.
- 现有的L-ASNase配方具有免疫性和快速清除等局限性.
- 聚氨酸通过促进瘤细胞的积累来增强L-ASNase的抗增殖活性,很可能是通过聚氨酸运输系统 (PTS) 受体.
研究的目的:
- 研究竞争性PTS受体抑制剂对L-ASNase与癌细胞相互作用的影响.
- 评估PTS在L-ASNase吸收和聚胺合物的细胞毒性中的作用.
主要方法:
- 来自不同来源的L-ASNase (RrA,EwA,EcA) 与天然的多氨酸 (精子胺,精子胺,氨酸) 和多乙烯胺 (PEI2) 结合使用碳胺化学.
- 细胞结合和摄取量使用度计和共聚焦显微镜量化.
- 评估了PTS受体竞争性配体对原生和结合L-ASNase的吸收和细胞毒性的影响.
主要成果:
- 聚胺结合显著增加了L-ASNase结合,细胞吸收和细胞毒性.
- 竞争性PTS配体,特别是聚胺的脂肪酸衍生物,降低了聚胺结合L-ASNase的吸收.
- 一些PTS配体也增强了本地L-ASNase的吸收,使本地和结合形式之间的吸收相等.
- 鉴定出精氨酸和酸/酸衍生物是PTS受体介导的内细胞酶的强有力的抑制剂,降低了聚胺结合L-ASNase的疗效.
结论:
- 聚胺运输系统 (PTS) 在L-ASNase内部化和细胞毒性活动中起着重要作用.
- 聚胺结合是一种可行的策略,通过向PTS来增强L-ASNase的输送和有效性.
- 相互作用是复杂的,取决于细胞类型和抑制剂特异性的,突出显示了需要量身定制的治疗方法.
更多相关视频
08:16Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
Published on: September 21, 2021
3.5K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
相关概念视频
Allosteric Proteins-ATCase
5.9K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
262
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
262
